LOS ANGELES, CA / ACCESSWIRE / May 16, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. ("LogicBio" ...

Los Angeles, California--(Newsfile Corp. - May 14, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. (NASDAQ: LOGC) ("LogicBio" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 3, 2018 and February 10, 2020, inclusive ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) between December 3, 2018 and February 10, 2020, inclusive (the "Class Period") of the important May 18, 2020 lead plaintiff deadline in the class action first filed by the firm. The lawsuit seeks to recover damages for LogicBio investors under the federal securities laws.

Los Angeles, California--(Newsfile Corp. - May 16, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. (NASDAQ: LOGC) ("LogicBio" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 3, 2018 and February 10, ...

LOS ANGELES, CA / ACCESSWIRE / May 14, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LogicBio Therapeutics, ...

LOS ANGELES, CA / ACCESSWIRE / May 18, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. ("LogicBio" ...

NEW YORK, NY / ACCESSWIRE / May 15, 20200 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against of LogicBio Therapeutics, Inc. ("LogicBio" ...

LOS ANGELES, CA / ACCESSWIRE / May 12, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. ("LogicBio" ...

NEW YORK, NY / ACCESSWIRE / May 17, 2020 / Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio Therapeutics, Inc. (NASDAQ:LOGC) between December 3, 2018 ...

Los Angeles, California--(Newsfile Corp. - May 17, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. (NASDAQ: LOGC) ("LogicBio" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 3, 2018 and February 10, 2020, inclusive ...

NEW YORK, NY / ACCESSWIRE / May 18, 20200 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against of LogicBio Therapeutics, Inc. ("LogicBio" ...

Los Angeles, California--(Newsfile Corp. - May 15, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. (NASDAQ: LOGC) ("LogicBio" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 3, 2018 and February 10, 2020, inclusive ...

LOS ANGELES, CA / ACCESSWIRE / May 17, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. ("LogicBio" ...

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against of LogicBio Therapeutics, Inc. ("LogicBio" or the Company") (NASDAQ: LOGC) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired LogicBio securities between December 3, 2018 and February 10, 2020, inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/logc.

Los Angeles, California--(Newsfile Corp. - May 13, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. (NASDAQ: LOGC) ("LogicBio" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 3, 2018 and February 10, 2020, inclusive ...

NEW YORK, May 15, 2020 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) between December.

NEW YORK, NY / ACCESSWIRE / May 15, 2020 / Pomerantz LLP is investigating claims on behalf of investors of LogicBio Therapeutics, Inc. ("LogicBio" or the "Company") (LOGC). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. The investigation concerns whether LogicBio and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

NEW YORK, NY / ACCESSWIRE / May 13, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against of LogicBio Therapeutics, Inc. ("LogicBio" or ...

Los Angeles, California--(Newsfile Corp. - May 12, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LogicBio Therapeutics, Inc. (NASDAQ: LOGC) ("LogicBio" or "the Company") for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 3, 2018 and February 10, 2020, inclusive ...

LOS ANGELES, CA / ACCESSWIRE / May 15, 2020 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LogicBio Therapeutics, ...